Literature DB >> 10526736

LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.

A Festa1, R D'Agostino, L Mykkänen, R P Tracy, C N Hales, B V Howard, S M Haffner.   

Abstract

OBJECTIVE: LDL particles are heterogeneous in terms of size and density; small dense LDL particles are considered more atherogenic than larger LDL particles. The aim of this study was to investigate the interrelationships among LDL size, insulin, proinsulin (intact and split), and insulin sensitivity in a tri-ethnic population with varying degrees of glucose tolerance (n = 1,549) in the Insulin Resistance Atherosclerosis Study. RESEARCH DESIGN AND METHODS: Insulin sensitivity was assessed by a frequently sampled intravenous glucose tolerance test with minimal model analysis. Proinsulin levels were measured using highly sensitive assays without detectable cross-reactivity with insulin, and LDL size was determined by gradient-gel electrophoresis.
RESULTS: In univariate analyses, LDL size was related to various features of the insulin resistance syndrome, including fasting insulin (r = -0.18), intact proinsulin (r = -0.24), split proinsulin (r = -0.24), the proinsulin-to-insulin ratio (r = -0.14), and insulin sensitivity (r = 0.21; all P < 0.0001). In a multivariate regression model (adjusted for age, BMI, ethnicity, and clinic), triglyceride levels (P = 0.0001), HDL cholesterol (P = 0.0001), sex (P = 0.002), and proinsulin (P = 0.01) were significantly related to LDL size. In the same model stratified by sex, LDL size was significantly inversely related to proinsulin in men (P = 0.005 and P = 0.04 after further adjustment for the glucose tolerance status), but not in women (P > 0.15).
CONCLUSIONS: We found an inverse relation of proinsulin to LDL particle size in a large tri-ethnic population with varying degrees of glucose tolerance. This relation was independent of age, BMI, and triglyceride and HDL cholesterol concentrations, and was more pronounced in men than in women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526736     DOI: 10.2337/diacare.22.10.1688

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

Review 1.  Small, dense low-density lipoprotein: risk or myth?

Authors:  Ngoc-Anh Le
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

2.  Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE).

Authors:  Toshitsugu Ishikawa; Hideki Ito; Yasuyoshi Ouchi; Yasuo Ohashi; Yasushi Saito; Haruo Nakamura; Hajime Orimo
Journal:  Curr Ther Res Clin Exp       Date:  2005-01

3.  The effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease.

Authors:  Riikka Lautamäki; Pirjo Nuutila; K E Juhani Airaksinen; Aila Leino; Heikki Hiekkanen; Marian Turiceanu; Murray Stewart; Juhani Knuuti; Tapani Rönnemaa
Journal:  Rev Diabet Stud       Date:  2006-05-10

Review 4.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

5.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

6.  Lipoprotein heterogeneity may help to detect individuals with insulin resistance.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Andreas Festa; Steven M Haffner
Journal:  Diabetologia       Date:  2015-09-04       Impact factor: 10.122

7.  Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography.

Authors:  Hisashi Mizutani; Toshinori Sako; Hiroko Okuda; Nobuaki Arai; Koji Kuriyama; Akihiro Mori; Itaru Yoshimura; Hidekazu Koyama
Journal:  J Vet Med Sci       Date:  2016-05-07       Impact factor: 1.267

Review 8.  Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome.

Authors:  Anouk E M Willems; Martina Sura-de Jong; André P van Beek; Esther Nederhof; Gertjan van Dijk
Journal:  Nutr Rev       Date:  2021-03-09       Impact factor: 7.110

9.  Gene Cascade Shift and Pathway Enrichment in Rat Kidney Induced by Acarbose Through Comparative Analysis.

Authors:  Chun-Yue Weng; Mo-Han Zhu; Ke-Lei Dai; Zhe-Yan Mi; Yuan-Shan Wang; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  Front Bioeng Biotechnol       Date:  2021-05-21

10.  Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study.

Authors:  Sara L White; Shahina Begum; Matias C Vieira; Paul Seed; Deborah L Lawlor; Naveed Sattar; Scott M Nelson; Paul Welsh; Dharmintra Pasupathy; Lucilla Poston
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.